The cyclosporin PSC 833 increases survival and delays engraftment of human multidrug-resistant leukemia cells in xenotransplanted NOD-SCID mice
Open Access
- 26 November 2002
- journal article
- Published by Springer Nature in Leukemia
- Vol. 16 (12) , 2388-2394
- https://doi.org/10.1038/sj.leu.2402663
Abstract
No abstract availableKeywords
This publication has 49 references indexed in Scilit:
- Human MDR 1 Protein Overexpression Delays the Apoptotic Cascade in Chinese Hamster Ovary FibroblastsBiochemistry, 1997
- Phosphatidylcholine and Phosphatidylethanolamine Behave as Substrates of the Human MDR1 P-GlycoproteinBiochemistry, 1997
- Functions of Ceramide in Coordinating Cellular Responses to StressScience, 1996
- Clinical trials of p-glycoprotein reversal in solid tumoursEuropean Journal Of Cancer, 1996
- MDR1/P-glycoprotein in haematological neoplasmsEuropean Journal Of Cancer, 1996
- Binding diversity of antibodies against external and internal epitopes of the multidrug resistance gene product P-glycoproteinCytometry, 1995
- Interleukin‐3 is an autocrine growth factor of human megakaryoblasts, the DAMI and MEG‐01 cellsBritish Journal of Haematology, 1994
- Resistance modification by PSC-833, a novel non-immunosuppressive cyclosporin AEuropean Journal of Cancer and Clinical Oncology, 1991
- A Model of Human Acute Lymphoblastic Leukemia in Immune-Deficient SCID MiceScience, 1989
- Multiple-Drug Resistance in Human CancerNew England Journal of Medicine, 1987